ELV (Elevance Health) Total Liabilities : $77,097 Mil (As of Mar. 2025)

View and export this data going back to 2001. Start your Free Trial

What is Elevance Health Total Liabilities?

Elevance Health's Total Liabilities for the quarter that ended in Mar. 2025 was $77,097 Mil.

Elevance Health's quarterly Total Liabilities increased from Sep. 2024 ($72,654.00 Mil) to Dec. 2024 ($75,463.00 Mil) and increased from Dec. 2024 ($75,463.00 Mil) to Mar. 2025 ($77,097.00 Mil).

Elevance Health's annual Total Liabilities increased from Dec. 2022 ($66,425.00 Mil) to Dec. 2023 ($69,523.00 Mil) and increased from Dec. 2023 ($69,523.00 Mil) to Dec. 2024 ($75,463.00 Mil).

Elevance Health Total Liabilities Historical Data

The historical data trend for Elevance Health's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elevance Health Total Liabilities Chart

Elevance Health Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

53,416.00

61,332.00

66,425.00

69,523.00

75,463.00

Elevance Health Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															71,184.00	70,691.00	72,654.00	75,463.00	77,097.00

Elevance Health Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Elevance Health's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	116889	-	41426
	=	75,463

Elevance Health's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	119717	-	42620
	=	77,097

Elevance Health Total Liabilities Related Terms

Thank you for viewing the detailed overview of Elevance Health's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Elevance Health Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Elevance Health Inc (NYSE:ELV) » Definitions » Total Liabilities

Comparable Companies

CVS CI HUM CNC MOH OSCR ALHC PGNY CLOV NEUE UNH SZSE:000503 BSP:ODPV3 NSE:MEDIASSIST BJSE:870656 BSP:QUAL3 MIL:HI ROCO:6665 PFHO

Traded in Other Exchanges

ELV:Mexico 0HG8:UK A58:Germany A58:Germany E1LV34:Brazil ELV:Austria

Address

220 Virginia Avenue, Indianapolis, IN, USA, 46204

Website

https://www.elevancehealth.com

Elevance Health remains one of the leading health insurers in the US, providing medical benefits to 46 million medical members as of December 2024. The company offers employer, individual, and government-sponsored coverage plans. Elevance differs from its peers in its unique position as the largest single provider of Blue Cross Blue Shield branded coverage, operating as the licensee for the Blue Cross Blue Shield Association in 14 states. Through acquisitions, such as the Amerigroup deal in 2012 and MMM in 2021, Elevance's reach expands beyond those states through government-sponsored programs, such as Medicaid and Medicare Advantage plans, too. It is also an emerging player in pharmacy benefit management and other healthcare services.

Executives

Mark Kaye	officer: EVP & CFO Designate	7 WORLD TRADE CENTER, 250 GREENWICH ST, NEW YORK NY 10007
Ronald W Penczek	officer: SVP, Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Kendrick Charles Morgan Jr	officer: EVP & President, Commercial	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Ramiro G Peru	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46260
Gail Boudreaux	director, officer: President and CEO	GENZYME CORP., 500 KENDALL STREET, CAMBRIDGE MA 02142
Dixon Robert L Jr	director	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Felicia F Norwood	officer: Exec VP & President, GBD	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Blair Williams Todt	officer: EVP and Chief Legal Officer	8735 HENDERSON ROAD, TAMPA FL 33625
Gloria M Mccarthy	officer: EVP, Office of the CEO	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Deanna D Strable-soethout	director	C/O PRINCIPAL FINANCIAL GROUP, 711 HIGH ST., DES MOINES IA 50392
Peter D Haytaian	officer: EVP & Pres., Govt. Bus. Div.	220 VIRGINIA AVE, INDIANAPOLIS IN 46204
Susan D. Devore	director	C/O PREMIER, INC., 13034 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Ryan M. Schneider	director	1680 CAPITAL ONE DRIVE, MCLEAN VA 22102
John E Gallina	officer: SVP & Chief Accounting Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Julie A Hill	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204